This inventor holds 1 USPTO granted patent. Top assignee: ETH Zurich. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Matthew Stephen Dunne: Inventor in Bacteriophage-Based Infection Treatment.
Introduction
Matthew Stephen Dunne is an inventor based in Zurich, Switzerland, and is associated with ETH Zurich. His work concerns bacterial infection and potential treatments using bacteriophages.
Latest Patents
Dunne is named on 1 patent: “Bacteriophages Producing Heterologous Bacteriocins.” The invention relates to medicine, specifically the treatment of bacterial infections, and describes bacteriophages that produce heterologous bacteriocins.
Career Highlights
Dunne’s listed patent connects his inventive work with research at ETH Zurich and the development of approaches to bacterial infection treatment.
Collaborations
His listed coworkers include Samuel Nando Kilcher and Susanne Andrea Meile.
Conclusion
Matthew Stephen Dunne’s patent work at ETH Zurich focuses on bacteriophage-based approaches to bacterial infection and its treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile